Progress of extrachromosomal DNA in promoting tumorigenesis, development and drug resistance
10.3760/cma.j.cn115355-20200622-00341
- VernacularTitle:染色体外DNA促进肿瘤发生、发展及耐药性的研究进展
- Author:
Youchao XIAO
;
Jiaqi HAO
;
Xingguang REN
;
Huan WANG
;
Hubin DUAN
- From:
Cancer Research and Clinic
2021;33(4):307-310
- CountryChina
- Language:Chinese
-
Abstract:
The application of biological technology and the deepening of tumor research have effectively improved the level of tumor diagnosis, treatment and clinical outcome prediction. However, the specific mechanisms of tumorigenesis and development are still unclear, and tumor drug resistance has also become an urgent problem that needs to be solved to improve the clinical outcome of patients. Considerable studies have shown that the extrachromosomal DNA (ecDNA) can promote tumorigenesis, development and drug resistance. EcDNA is a looser, rounded form of DNA with unique genetic properties that carry specific genes and regulatory elements. This paper will discuss the biological characteristics, tumor-promoting mechanisms and drug resistance-facilitating of ecDNA.
